keePAP Overview
- Founded
-
2012

- Status
-
Private
- Employees
-
20

- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$15.2M
- Investors
-
9
keePAP General Information
Description
Developer of a wearable device intended to treat obstructive sleep apnea. The company offers a device that is light in weight, with an unobtrusive nasal interface and a miniature battery-operated control unit that make it convenient for use both at home and while traveling, enabling patients to restore normal breathing gently and effectively, and ensure a good night's sleep.
Contact Information
Website
www.keepap.com
Formerly Known As
Ninnox Medical
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
- Moshe Sharett 29
- Rishon Le Zion 7570450
- Israel
+972 00-000-0000
keePAP Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Later Stage VC (Series C) | 02-Sep-2020 | $15.2M | 000.00 | 000.00 | Completed | Generating Revenue |
3. Early Stage VC (Series B) | 29-Apr-2015 | 0000 | 000.00 | 000.00 | Completed | Generating Revenue |
2. Early Stage VC (Series A) | 10-Jun-2012 | $630K | $630K | 00.000 | Completed | Startup |
1. Accelerator/Incubator | Completed | Startup |
keePAP Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Preferred C3 | 000,000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | ||
Preferred C2 | 0,000,000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | ||
Preferred C1 | 000,000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | ||
Preferred B2 | 000,000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | ||
Preferred B1 | 1,352,728 | $4.64 | $4.64 | 1x | $4.64 | 21.39% | ||
Preferred A | 690,909 | $1.05 | $1.05 | 1x | $1.05 | 9.49% |
keePAP Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a wearable device intended to treat obstructive sleep apnea. The company offers a device that is light in w
Therapeutic Devices
Rishon Le Zion, Israel
20
As of 2022
000.00
00.00
0000-00-00
00000000000
000.00
keePAP Competitors (3)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Somnics | Formerly VC-backed | Zhubei, Taiwan | 00 | 00000000 | ||
0000000 0000000 00 | Formerly VC-backed | Maple Grove, MN | 000 | 00000 | 00000000 | 00000 |
00000000 0000000 | Corporate Backed or Acquired | Santa Clara, CA | 000000&0 |
keePAP Executive Team (3)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Alex Rapoport | Founder, Chief Executive Officer & Board Member | ||
Rami Shmueli | Research & Development Manager | ||
Anne Reiser | Executive Chairperson |
keePAP Board Members (7)
Name | Representing | Role | Since |
---|---|---|---|
Anne Reiser | Self | Executive Chairperson | 000 0000 |
Daniel Bertholet | 4See Ventures | Board Member | 000 0000 |
Eli Sorzon | Xenia Venture Capital | Board Member | 000 0000 |
Valérie Calenda Ph.D | Mérieux Equity Partners | Board Member | 000 0000 |
keePAP Signals
keePAP Investors (9)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
4See Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
Celeste Management | Family Office | Minority | 000 0000 | 000000 0 | |
Financière Arbevel | PE-Backed Company | Minority | 000 0000 | 000000 0 | |
C4 Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
Lavorel Groupe | PE-Backed Company | Minority | 000 0000 | 000000 0 |